Inhaled mannitol as treatment for children with cystic fibrosis

A. Bush (London, United Kingdom)

Source: Annual Congress 2008 - The use of inhaled mannitol for assessing airway disease
Session: The use of inhaled mannitol for assessing airway disease
Session type: Symposium
Number: 1308
Disease area: Paediatric lung diseases

Slide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Bush (London, United Kingdom). Inhaled mannitol as treatment for children with cystic fibrosis. Annual Congress 2008 - The use of inhaled mannitol for assessing airway disease

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Inhaled steroids in children with non-cystic fibrosis bronchiectasis
Source: Eur Respir J 2004; 24: Suppl. 48, 392s
Year: 2004

Optimising inhaled mannitol for cystic fibrosis in an adult population
Source: Breathe 2015; 11:39-48
Year: 2015



Inhalation therapy in cystic fibrosis
Source: School Course 2013 - Cystic Fibrosis
Year: 2013

Benefit of aerosol therapy with pulmozyme for children with cystic fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 622s
Year: 2005

Inhaled antibiotics in cystic fibrosis: what we should do and what we still do not know
Source: International Congress 2016 – PG13 Inhaled antibiotics in respiratory infections
Year: 2016


Prescription of Inhaled corticosteroid in non-cystic fibrosis bronchiectasis:a solution or a problem
Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease
Year: 2020


Safety, tolerability and efficacy of intravenous aminophylline in adult patients with pulmonary exacerbations of cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Year: 2014

Inhaled colistin following lung transplantation in colonised cystic fibrosis patients
Source: Eur Respir J 2013; 42: 542-544
Year: 2013


Inhaled antibiotics in non-cystic fibrosis bronchiectasis: better than oral antibiotics?
Source: International Congress 2016 – PG13 Inhaled antibiotics in respiratory infections
Year: 2016



Inhaled corticosteroids and lower lung function decline in young children with cystic fibrosis
Source: Eur Respir J 2011; 37: 1091-1095
Year: 2011



Inhaled mannitol in cystic fibrosis: clinical experience in Verona CF centre
Source: Virtual Congress 2020 – New insights into respiratory physiotherapy
Year: 2020


Long-term administration of aerosolised tobramycin in patients with cystic fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 619s
Year: 2005

Long-term tiotropium bromide therapy was retrospectively analyzed in adults with cystic fibrosis
Source: International Congress 2015 – Cystic fibrosis: assessment and treatment
Year: 2015

A pilot study of inhaled dry-powder mannitol during cystic fibrosis-related pulmonary exacerbation
Source: Eur Respir J 2015; 45: 541-544
Year: 2015


Glucose tolerance during pulmonary exacerbations in children with cystic fibrosis
Source: Annual Congress 2011 - Cystic fibrosis: new basic, clinical and bacteriological knowledge
Year: 2011


The efficacy and tolerability of inhaled hypertonic saline in children with cystic fibrosis
Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis
Year: 2020

Inhaled therapy in cystic fibrosis: agents, devices and regimens
Source: Breathe 2015; 11:110-118
Year: 2015